Approval · Notice of Compliance 28585 · 2022
OXYNEO: Notice of Compliance 28585
Issued July 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28585
- Date
- July 14, 2022
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Update and Conversion to the 2020 Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXYNEO | Not yet assigned | — |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 10 MG per TAB
- OXYCODONE HYDROCHLORIDE 15 MG per TAB
- OXYCODONE HYDROCHLORIDE 20 MG per TAB
- OXYCODONE HYDROCHLORIDE 30 MG per TAB
- OXYCODONE HYDROCHLORIDE 40 MG per TAB
- OXYCODONE HYDROCHLORIDE 60 MG per TAB
- OXYCODONE HYDROCHLORIDE 80 MG per TAB